Growth in the nuclear medicine market can primarily be attributed to factors such as cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99 and the increasing incidence and prevalence of cancer. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
According to the new market research report Clinical Microbiology Market is projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%. The increasing prevalence of infectious diseases and growing outbreak of epidemics (such as COVID-19), increased funding and public-private investments and technological advancements are the key factors driving the growth of the orthopedic braces and supports the industry.
The COVID-19 pandemic has led to major changes in the clinical operations of radiology departments worldwide. In parallel with clinical preparedness activities, academic medical centers and universities were rushed to shut down scientific research activities to maximize social distancing and minimize the spread of infection to research staff and others with whom they might have contact. Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Largely unknown before the outbreak began in Wuhan, China, in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.
The SPECT applications is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. Based on application, the nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The thyroid applications segment is projected to register the highest growth rate in the forecast period. The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders.
Some of the prominent players operating in the market BioMérieux (France), Dickinson and Company (US), Abbott Laboratories (US), Danaher Corporation (US), Becton and Roche Diagnostics (Switzerland). Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219135367